7-48192983-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP4_StrongBP6_Very_StrongBS2
The NM_152701.5(ABCA13):c.94T>C(p.Trp32Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000674 in 1,533,322 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00080 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 5 hom. )
Consequence
ABCA13
NM_152701.5 missense
NM_152701.5 missense
Scores
9
4
3
Clinical Significance
Conservation
PhyloP100: 4.07
Publications
0 publications found
Genes affected
ABCA13 (HGNC:14638): (ATP binding cassette subfamily A member 13) In human, the ATP-binding cassette (ABC) family of transmembrane transporters has at least 48 genes and 7 gene subfamilies. This gene is a member of ABC gene subfamily A (ABCA). Genes within the ABCA family typically encode several thousand amino acids. Like other ABC transmembrane transporter proteins, this protein has 12 or more transmembrane alpha-helix domains that likely arrange to form a single central chamber with multiple substrate binding sites. It is also predicted to have two large extracellular domains and two nucleotide binding domains as is typical for ABCA proteins. Alternative splice variants have been described but their biological validity has not been demonstrated.[provided by RefSeq, Mar 2009]
ABCA13 Gene-Disease associations (from GenCC):
- schizophreniaInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 8: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Eigen, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.011801094).
BP6
Variant 7-48192983-T-C is Benign according to our data. Variant chr7-48192983-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 724010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 5 Unknown gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA13 | NM_152701.5 | c.94T>C | p.Trp32Arg | missense_variant | Exon 2 of 62 | ENST00000435803.6 | NP_689914.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA13 | ENST00000435803.6 | c.94T>C | p.Trp32Arg | missense_variant | Exon 2 of 62 | 1 | NM_152701.5 | ENSP00000411096.1 | ||
ABCA13 | ENST00000417403.5 | n.94T>C | non_coding_transcript_exon_variant | Exon 2 of 18 | 2 | ENSP00000409268.1 |
Frequencies
GnomAD3 genomes AF: 0.000802 AC: 122AN: 152072Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
122
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00196 AC: 272AN: 138926 AF XY: 0.00201 show subpopulations
GnomAD2 exomes
AF:
AC:
272
AN:
138926
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000660 AC: 911AN: 1381250Hom.: 5 Cov.: 31 AF XY: 0.000680 AC XY: 463AN XY: 681154 show subpopulations
GnomAD4 exome
AF:
AC:
911
AN:
1381250
Hom.:
Cov.:
31
AF XY:
AC XY:
463
AN XY:
681154
show subpopulations
African (AFR)
AF:
AC:
2
AN:
31380
American (AMR)
AF:
AC:
11
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
AC:
657
AN:
25130
East Asian (EAS)
AF:
AC:
0
AN:
35664
South Asian (SAS)
AF:
AC:
0
AN:
77534
European-Finnish (FIN)
AF:
AC:
0
AN:
34904
Middle Eastern (MID)
AF:
AC:
0
AN:
5684
European-Non Finnish (NFE)
AF:
AC:
122
AN:
1077966
Other (OTH)
AF:
AC:
119
AN:
57788
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
42
85
127
170
212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000802 AC: 122AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.000781 AC XY: 58AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
122
AN:
152072
Hom.:
Cov.:
32
AF XY:
AC XY:
58
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41414
American (AMR)
AF:
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
99
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
16
AN:
68014
Other (OTH)
AF:
AC:
4
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
77
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 19, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ABCA13: BS1 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Pathogenic
D
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Vest4
MutPred
Gain of methylation at W32 (P = 0.0175);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.